Lymphokine-activated killer (LAK) and monocyte-mediated cytotoxicity on tumor cell lines resistant to antitumor agents

This publication has 10 references indexed in Scilit:

• SUSCEPTIBILITY OF CHEMORESISTANT MURINE AND HUMAN-TUMOR CELLS TO LYSIS BY INTERLEUKIN 2-ACTIVATED LYMPHOCYTES
  1988
• The cell biology of multiple drug resistance
  Biochemical Pharmacology, 1987
• Human tumor cell lines with pleiotropic drug resistance are efficiently killed by interleukin‐2 activated killer cells and by activated monocytes
  International Journal of Cancer, 1987
• A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 Alone
  New England Journal of Medicine, 1987
• Overexpression of a novel anionic glutathione transferase in multidrug-resistant human breast cancer cells.
  Journal of Biological Chemistry, 1986
• Isolation and characterization of a human colon adenocarcinoma cell line resistant to doxorubicin
  British Journal of Cancer, 1986
• RESISTANCE TO NATURAL-KILLER CELL-MEDIATED CYTOLYSIS BY A PLEIOTROPIC DRUG-RESISTANT HUMAN ERYTHROLEUKEMIA (K562-R) CELL-LINE
  1986
• Correlation of Tumor Growth Inhibitory Activity of Macrophages Exposed to Adriamycin and Adriamycin Sensitivity of the Target Tumor Cells234
  JNCI Journal of the National Cancer Institute, 1984
• Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
  The Journal of Immunology, 1984
• Tumoricidal activity of macrophages isolated from human ascitic and solid ovarian carcinomas: Augmentation by interferon, lymphokines and endotoxin
  International Journal of Cancer, 1981